跳至主要内容
临床试验/NCT05599763
NCT05599763已完成不适用

Real-life Study Evaluating the Performance of 2% Aqueous Eosin in Children With Diaper Rash

Cooperation Pharmaceutique Francaise1 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2022年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
67
试验地点
1
主要终点
Percentage of patients with an SSDDS score < 3/6 or an improvement of at least 2 points

研究概览

简要总结

This study is being conducted to provide updated clinical data on safety and performance (demonstrated previously for CE marking under the Medical Devices Directive) Cooper Aqueous Eosin 2%. This is an observational study conducted under real-life conditions and as part of post-marketing surveillance activity for a device that has been on the market for a long time and a well-established technology, in accordance with the Medical Devices Regulations 2017 /745 (MDR) and MDCG 2020-6 guidelines.

The study will be a multicenter, national, observational, prospective study, with a 7-day follow-up (+/- 2 day). 60 patients are scheduled.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children under 24 months
  • With diaper rash for which a prescription for 2% aqueous eosin in a 50 ml vial is made
  • SSDDS score >= 3/6
  • Not requiring hospitalization
  • Written consent of one of the parents
  • Affiliated with social security
  • Acceptance of one of the parents to participate in a visit on day 7 in the office or, in case of impossibility, with video/internet consultation or with consultation by phone and sending a photo in this case by the parent(s).

排除标准

  • Antibiotic therapy in progress or prescribed on day 0, or other local therapeutic topicals prescribed on day 0
  • Children with wounds or likely to be allergic to 2% aqueous eosin or to one of the components of 2% aqueous eosin.
  • Ongoing diarrhoea (change in the consistency of stools (loose or watery) and / or an increase in the number (≥ 3 stools / day).

结局指标

主要结局

Percentage of patients with an SSDDS score < 3/6 or an improvement of at least 2 points

时间窗: at day 7 +-2 days

The SSDDS (Scoring System for Diaper Dermatitis Scale) score is a severity score : the sum of the scores for four areas: severity of erythema and irritation (score from 0 to 3), extension (0 to 1), presence of papules or pustules (0 to 1) and open skin (0 to 1). The possible scores range from 0 (fair skin) to 6 (extensive diaper rash including intense erythema, papules or pustules and open skin with lesion of the dermis).

次要结局

  • Percentage of patients completely cured(at day 7 +/-2 days)
  • Change of the SSDDS score between day 0 and day 7(at day 7 +/-2 days)
  • Assessment of compliance(at day 7 +/-2 days)
  • Healing time according to parent(up to 9 days)
  • Assessment of tolerance(at day 7 +/-2 days)
  • Change in associated signs between day 0 and day 7(at day 7 +/-2 days)

研究者

发起方
Cooperation Pharmaceutique Francaise
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验